|
Michael Kurman, M.D. is an independent consultant to the pharmaceutical, biotechnology and health care industries specializing in oncology and oncology drug development, with 24 years of experience. He received his B.S. in Biology from Syracuse University graduating summa cum laude and received his M.D. degree from Cornell University Medical College. Dr. Kurman started his career in the practice of oncology, during which he was an investigator on several oncology clinical trials. Since joining industry, he has held positions of progressively more responsibility in Janssen, Cytogen and US Bioscience, and was involved in the successful development or launch of four oncology products. Before starting his consultancy, Dr. Kurman was Vice President of Clinical Operations for Quintiles’ Oncology Division. His primary interests are in early/late phase oncology clinical trial design and drug development, and in strategic portfolio management. In addition, he serves on the Scientific Advisory Boards of several companies and is on the Board of Directors of Avalon Pharmaceuticals. Dr. Kurman is board certified in Internal Medicine and Oncology, and did his oncology training at Mt. Sinai Hospital in New York. | 